| Financial Year |
March 31 2023 |
| Monetary Funds |
6,054,163,312.00 |
| Held-for-trading Financial Assets |
1,835,201,858.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
707,992,919.00 |
| Advances to Suppliers |
212,037,848.00 |
| Other Receivables |
81,356,617.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
999,384,770.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,577,275,828.00 |
| Total Current Assets |
11,469,566,055.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
389,829,618.00 |
| Fixed Assetes |
7,382,020,776.00 |
| Under-construction Projects |
1,335,354,547.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
559,819,182.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,752,739.00 |
| Deferred Income Tax Assets |
88,311,062.00 |
| Other Non-Current Assets |
346,084,915.00 |
| Sub-Total of Non-Current Assets |
10,963,164,182.00 |
| Total Assets |
22,432,730,237.00 |
| Short-Term Loans |
3,135,281,758.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
30,997,354.00 |
| Accounts Payable |
554,686,168.00 |
| Accounts Received In Advance |
3,145,000.00 |
| Employee Compensation Payable |
86,061,203.00 |
| Taxes Payable |
28,840,198.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
196,452,927.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,978,490.00 |
| Other Current Liabilities |
3,261,586.00 |
| Sub-Total of Current Liabilities |
4,313,398,663.00 |
| Long-term Loans |
300,000.00 |
| Bonds Payable |
1,553,320.00 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,083,755,046.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,213,712,837.00 |
| Total Liabilities |
6,527,111,500.00 |
| Paid-In Capital(Or Share Stock) |
658,879,568.00 |
| Capital Surplus |
1,312,600,389.00 |
| Surplus Reserve |
204,763,967.00 |
| LESS:Treasury Stock |
249,286,860.00 |
| Undistributed Profits |
13,714,167,844.00 |
| Minority Stockholder's Interest |
249,213,586.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
15,656,405,151.00 |
| Owner's Equity（Stockholder's Equity） |
15,905,618,737.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
22,432,730,237.00 |
